Literature DB >> 7582293

Clinical isolates of Mycobacterium simiae in San Antonio, Texas. An 11-yr review.

G Valero1, J Peters, J H Jorgensen, J R Graybill.   

Abstract

During a period of 11 yr (1983-1993) 137 clinical isolates of Mycobacterium simiae obtained from 75 patients were identified in a University hospital in San Antonio, Texas. One hundred twenty-eight isolates (93%) were from a pulmonary source, four (3%) from blood, and five from other sites including skin, urine, lymph node, bone marrow, and brain. Of 62 evaluable patients, six (10%) had definite infection, nine (14%) had probable disease, and 48 (76%) were thought to be colonized. During the last 2 yr of the study (1992 and 1993), M. simiae became the second most frequently isolated nontuberculous mycobacterium at this institution surpassed only by Mycobacterium avium complex. There are limited data about effective treatment for this multidrug-resistant organism. New macrolides, quinolones, ethambutol, clofazimine, and aminoglycosides are promising therapeutic agents.

Entities:  

Mesh:

Year:  1995        PMID: 7582293     DOI: 10.1164/ajrccm.152.5.7582293

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  12 in total

1.  Nontuberculous Mycobacterial Infections of the Lung.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-06       Impact factor: 3.725

Review 2.  Nontuberculous mycobacteria and the lung: from suspicion to treatment.

Authors:  Emmet E McGrath; Zoe Blades; Josie McCabe; Hannah Jarry; Paul B Anderson
Journal:  Lung       Date:  2010-04-09       Impact factor: 2.584

3.  Treatment of Non-Tuberculous Mycobacterial Lung Disease.

Authors:  Julie V Philley; Mary Ann DeGroote; Jennifer R Honda; Michael M Chan; Shannon Kasperbauer; Nicholas D Walter; Edward D Chan
Journal:  Curr Treat Options Infect Dis       Date:  2016-10-11

4.  A molecular epidemiological study of Mycobacterium simiae isolated from AIDS patients in Guadeloupe.

Authors:  E Legrand; A Devallois; L Horgen; N Rastogi
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

5.  Clinical, Radiological, and Microbiological Characteristics of Mycobacterium simiae Infection in 97 Patients.

Authors:  Nathalie Coolen-Allou; Thomas Touron; Olivier Belmonte; Virgile Gazaille; Michel Andre; Jérôme Allyn; Sandrine Picot; Annabelle Payet; Nicolas Veziris
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

6.  Pulmonary Mycobacterium simiae infection: comparison with pulmonary tuberculosis.

Authors:  C Maoz; D Shitrit; Z Samra; N Peled; L Kaufman; M R Kramer; J Bishara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-17       Impact factor: 3.267

7.  Refractory bacteremia and osteomyelitis resulting in fatal bacteremic pneumonia with multiorgan failure caused by Mycobacterium simiae in a non-human immunodeficiency Virus-Infected Adult.

Authors:  Kuei-Pin Chung; Tzu-Hsiu Tsai; Yu-Tsung Huang; Po-Ren Hsueh
Journal:  J Clin Microbiol       Date:  2009-09-02       Impact factor: 5.948

8.  Computed Tomography Findings of Pulmonary Mycobacterium simiae Infection.

Authors:  Ayeh Baghizadeh; Payam Mehrian; Poopak Farnia
Journal:  Can Respir J       Date:  2017-01-03       Impact factor: 2.409

9.  Iatrogenic Mycobacterium simiae skin infection in an immunocompetent patient.

Authors:  Jaime Piquero; Vanesa Piquero Casals; Edgar Larotta Higuera; Mitchell Yakrus; David Sikes; Jacobus H de Waard
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

10.  Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel.

Authors:  Isaac Levy; Galia Grisaru-Soen; Liat Lerner-Geva; Eitan Kerem; Hana Blau; Lea Bentur; Micha Aviram; Joseph Rivlin; Elie Picard; Anita Lavy; Yakov Yahav; Galia Rahav
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.